Non-comparative phase II study of bendamustine hydrochloride in patients with pretreated soft tissue sarcoma (German Sarcoma Group-AIO 001).

被引：0
|
作者：
Mayer, F.
Schleicher, J.
Huober, J.
Meisinger, I.
Pintoffl, J.
Kaefer, G.
Gruenwald, V.
Burkart, C.
Kanz, L.
Hartmann, J. T.
机构：
[1] Univ Tuebingen, Tubingen, Germany
[2] Katharinen Hosp, D-70174 Stuttgart, Germany
[3] Krankenhaus Sigmaringen, Sigmaringen, Germany
[4] Hannover Med Sch, D-3000 Hannover, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9525
引用
收藏
页码：526S / 526S
页数：1
相关论文
共 50 条
  • [21] Indeterminate pulmonary nodules in non-rhabdomyosarcoma soft tissue sarcoma: A study of the European paediatric Soft Tissue Sarcoma Study Group
    Giraudo, Chiara
    Schoot, Reineke
    Cardoen, Liesbeth
    Stramare, Roberto
    Coppadoro, Beatrice
    Bisogno, Gianni
    Bouhamama, Amine
    Brennan, Bernadette
    Brisse, Herve J.
    Orbach, Daniel
    Coma, Ana
    Di Paolo, Pier Luigi
    Fayard, Cindy
    McDonald, Leigh
    Moalla, Salma
    Morosi, Carlo
    Pace, Erika
    Tang, Vivian
    van Noesel, Max M.
    Ferrari, Andrea
    van Rijn, Rick
    CANCER, 2024, 130 (04) : 597 - 608
  • [22] Activity of regorafenib in advanced pretreated soft tissue sarcoma Results of a single-center phase II study
    Marrari, Andrea
    Bertuzzi, Alexia
    Bozzarelli, Silvia
    Gennaro, Nicolo
    Giordano, Laura
    Quagliuolo, Vittorio
    De Sanctis, Rita
    Sala, Simona
    Balzarini, Luca
    Santoro, Armando
    MEDICINE, 2020, 99 (26) : E20719
  • [23] Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group phase II study
    Saeter, G
    Alvegard, TA
    Monge, OR
    Strander, H
    Turesson, I
    Klepp, R
    Soderberg, M
    Wist, E
    Raabe, N
    Erlanson, M
    Solheim, OP
    Hannisdal, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) : 1551 - 1558
  • [24] MITOMYCIN-C (MCC) IN ADVANCED SOFT-TISSUE SARCOMA - A PHASE-II STUDY OF THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    VANOOSTEROM, AT
    SANTORO, A
    BRAMWELL, V
    DAVY, M
    MOURIDSEN, HT
    THOMAS, D
    SYLVESTER, R
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04): : 459 - 461
  • [25] Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
    Palmerini, Emanuela
    Sanfilippo, Roberta
    Grignani, Giovanni
    Buonadonna, Angela
    Romanini, Antonella
    Badalamenti, Giuseppe
    Ferraresi, Virginia
    Vincenzi, Bruno
    Comandone, Alessandro
    Pizzolorusso, Antonio
    Brunello, Antonella
    Gelsomino, Fabio
    De Pas, Tommaso
    Ibrahim, Toni
    Grosso, Federica
    Zanelli, Francesca
    Pantaleo, Maria Abbondanza
    Milesi, Laura
    Ciuffreda, Libero
    Ferrari, Vittorio
    Marchesi, Emanuela
    Quattrini, Irene
    Righi, Alberto
    Setola, Elisabetta
    Carretta, Elisa
    Picci, Piero
    Ferrari, Stefano
    CANCERS, 2021, 13 (05) : 1 - 15
  • [26] Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma
    Bailey, Howard H.
    Mahoney, Michelle R.
    Ettinger, David S.
    Maples, William J.
    Fracasso, Paula M.
    Traynor, Anne M.
    Erlichman, Charles
    Okuno, Scott H.
    CANCER, 2006, 107 (10) : 2462 - 2467
  • [27] Phase II trial of paclitaxel in patients with soft-tissue sarcoma
    Casper, ES
    Waltzman, RJ
    Schwartz, GK
    Sugarman, A
    Pfister, D
    Ilson, D
    Woodruff, J
    Leung, D
    Bertino, JR
    CANCER INVESTIGATION, 1998, 16 (07) : 442 - 446
  • [28] Response of Children with Stage IV Soft Tissue Sarcoma to Topotecan and Carboplatin: A Phase II Window Trial of the Cooperative Soft Tissue Sarcoma Group
    Bochennek, K.
    Dantonello, T.
    Koscielniak, E.
    Claviez, A.
    Dirksen, U.
    Sauerbrey, A.
    Beilken, A.
    Klingebiel, T.
    KLINISCHE PADIATRIE, 2013, 225 (06): : 309 - 314
  • [29] Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Preliminary results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) for the non-L sarcoma cohort.
    Pink, Daniel
    Andreou, Dimosthenis
    Florcken, Anne
    Golf, Alexander
    Richter, Stephan
    Kessler, Torsten
    Kortum, Martin
    Schmidt, Christian Andreas
    Kasper, Bernd
    Wardelmann, Eva
    Bahr, Jeanette
    Mueller, Daniel Wilhelm
    Sookthai, Disorn
    Al-Batran, Salah-Eddin
    Reichardt, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study.
    Gelderblom, H.
    Blay, J.
    Seddon, B. M.
    Leahy, M.
    Ray-Coquard, I. L.
    De Brauwer, A.
    Veyt, E.
    Weitman, S. D.
    Hogendoorn, P. C.
    Hohenberger, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345